The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V09 | Diagnostic radiopharmaceuticals | |
| 3 | V09I | Tumour detection | |
| 4 | V09IA | Technetium (99mTc) compounds |
| Code | Title | |
|---|---|---|
| V09IA01 | Technetium (99mTc) antiCarcinoEmbryonicAntigen antibody | |
| V09IA02 | Technetium (99mTc) antimelanoma antibody | |
| V09IA03 | Technetium (99mTc) pentavalent succimer | |
| V09IA04 | Technetium (99mTc) votumumab | |
| V09IA05 | Technetium (99mTc) depreotide | |
| V09IA06 | Technetium (99mTc) arcitumomab | |
| V09IA07 | ||
| V09IA09 | ||
| V09IA10 |
| Active Ingredient | Description | |
|---|---|---|
| Technetium ⁹⁹ᵐTc hynic-octreotide |
Technetium ⁹⁹ᵐTc hynic-octreotide is for diagnostic use only. Technetium (99mTc) labelled EDDA/HYNIC-TOC binds with high affinity to somatostatin receptor subtypes 2 and 5, also to subtype 3 but with lesser affinity. |
|
| Technetium ⁹⁹ᵐTc tilmanocept |
Technetium ⁹⁹ᵐTc tilmanocept is a receptor-targeted radiopharmaceutical that is designed to rapidly transit lymphatic vessels; it biotargets, accumulates, and is retained in primary, key predictive, draining lymph nodes (sentinel lymph nodes). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| LYMPHOSEEK Kit for radiopharmaceutical preparation | European Medicines Agency (EU) | MPI, EU: SmPC |
